DAWSON MICHAEL JOHN (Chief Medical Officer) purchased 15K shares of PALISADE BIO, INC. on the open market
Open‑market purchase worth $17.1K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/31/2022ACC: 0001209191-22-021681
Officer· Chief Medical Officer
Since Apr 2021
+15K
Net shares
Net buyer
$17.1K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
15K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+15K
Price / share
$1.14
Trade value
$17.09K
% of position
New position
3/29/2022
0.00→15K
Total
Net shares
+15K
Net value
$17.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/29/2022 | P · Purchase | +15K | $1.14 | $17.09K | New position | 0.00 | 15K |
| Total | +15K | $17.09K | ||||||
Derivative Transactions0
No derivative transactions reported